World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
83
Citations
22741
World Ranking
908
National Ranking
74

Axel Schambach publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Axel Schambach sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 426 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Axel Schambach D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Axel Schambach sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Axel Schambach is affiliated with Hannover Medical School in Germany and has an extensive research portfolio focusing on biochemistry, genetics, and molecular biology. Their scholarly work spans over 200 publications, with significant contributions also in medicine.

Schambach's research interests cover a range of subfields including molecular biology, oncology, immunology, genetics, and physiology. A key focus area is CAR-T cell therapy research, which accounts for 116 publications. They also have a substantial number of works related to CRISPR and genetic engineering, virus-based gene therapy research, immune cell function and interaction, pluripotent stem cells research, viral infectious diseases and gene expression in insects, as well as RNA interference and gene delivery.

The frequent venues where Schambach's research is published include Frontiers in Immunology, Human Gene Therapy, bioRxiv (Cold Spring Harbor Laboratory), Molecular Therapy, and Blood. These journals highlight a consistent presence in both immunology and gene therapy fields.

Recent notable papers authored or coauthored by Schambach include:

  • Betibeglogene Autotemcel Gene Therapy for Non-β 00 Genotype β-Thalassemia, 2021, New England Journal of Medicine
  • Cell transcriptomic atlas of the non-human primate Macaca fascicularis, 2022, Nature
  • Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells, 2020, Frontiers in Immunology
  • Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model, 2021, Journal of Hepatology
  • Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis, 2022, Nature Communications

Their research collaborations include frequent coauthors such as Michael Morgan with 44 joint publications, Michael Rothe with 30, Adrian Schwarzer with 16, Katharina Zimmermann with 14, and Hildegard Büning with 12.

Best Publications

  • Skin tissue generation by laser cell printing.

    Lothar Koch;Andrea Deiwick;Sabrina Schlie;Stefanie Michael

  • Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

    Christian Jörg Braun;Kaan Boztug;Anna Paruzynski;Maximilian Witzel

  • Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors

    Ute Modlich;Susana Navarro;Daniela Zychlinski;Tobias Maetzig

  • A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency

    Salima Hacein-Bey-Abina;Sung Yun Pai;H. Bobby Gaspar;Myriam Armant

  • A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage.

    Jianwei Wang;Qian Sun;Yohei Morita;Hong Jiang

  • Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity

    Ute Modlich;Jens Bohne;Manfred Schmidt;Christof von Kalle

  • Long noncoding RNA Chast promotes cardiac remodeling.

    Janika Viereck;Regalla Kumarswamy;Ariana Foinquinos;Ke Xiao

  • Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors

    Daniela Zychlinski;Axel Schambach;Ute Modlich;Tobias Maetzig

  • Gene therapy on the move

    Kerstin B. Kaufmann;Hildegard Büning;Anne Galy;Axel Schambach;Axel Schambach

  • The phenotype of human STK4 deficiency

    Hengameh Abdollahpour;Giridharan Appaswamy;Daniel Kotlarz;Daniel Kotlarz;Jana Diestelhorst;Jana Diestelhorst

  • Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming

    Eva Warlich;Johannes Kuehle;Tobias Cantz;Tobias Cantz;Martijn H Brugman

  • Gammaretroviral vectors: biology, technology and application.

    Tobias Maetzig;Melanie Galla;Christopher Baum;Axel Schambach

  • Advantages and applications of CAR-expressing natural killer cells.

    Wolfgang Glienke;Ruth Esser;Christoph Priesner;Julia D. Suerth

  • Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome

    Daniel Kotlarz;Natalia Ziętara;Gulbu Uzel;Thomas Weidemann

  • Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.

    Maurice Labuhn;Felix F. Adams;Michelle Ng;Sabine Knoess

  • NAMPT is essential for the G-CSF–induced myeloid differentiation via a NAD + –sirtuin-1–dependent pathway

    Julia Skokowa;Dan Lan;Basant Kumar Thakur;Fei Wang

  • Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy.

    Eirini P Papapetrou;Axel Schambach;Axel Schambach

  • Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral Vectors

    Axel Schambach;Harald Wodrich;Markus Hildinger;Jens Bohne

  • LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia

    Julia Skokowa;Gunnar Cario;Murat Uenalan;Axel Schambach

  • Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies

    Nico Lachmann;Mania Ackermann;Eileen Frenzel;Steffi Liebhaber

Frequent Co-Authors

Christopher Baum
Christopher Baum Charité - University Medicine Berlin
Adrian J. Thrasher
Adrian J. Thrasher University College London
David A. Williams
David A. Williams Boston Children's Hospital
Doris Steinemann
Doris Steinemann Hannover Medical School
Brigitte Schlegelberger
Brigitte Schlegelberger Hannover Medical School
Gudrun Göhring
Gudrun Göhring Hannover Medical School
Hans R. Schöler
Hans R. Schöler Max Planck Society
Fulvio Mavilio
Fulvio Mavilio University of Modena and Reggio Emilia
Ulrich Martin
Ulrich Martin Hannover Medical School
Ulrike Koehl
Ulrike Koehl Leipzig University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in Molecular Biology opens doors to a wide range of online graduate programs and diverse careers. Graduates can build upon their scientific foundation by pursuing advanced studies in fields such as counseling, psychology, and mental health. These areas offer high-impact career opportunities for those interested in both research and helping others.

For example, some molecular biology graduates transition into health services by enrolling in a master of mental health online program. Others leverage their background in life sciences along with specialized training to explore what can you do with a masters in forensic psychology, contributing to criminal investigations or legal proceedings.

Many online programs are tailored for working professionals, making it feasible to earn a masters in child psychology online, or to explore a variety of online masters degrees in counseling. These programs complement a molecular biology education by broadening your expertise and expanding your career options in healthcare, education, forensics, and wellness.

Best Scientists Citing Axel Schambach

Trending Scientists

Recently Published Articles